FDA Approved: XTANDI — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

XTANDI (enzalutamide) received FDA approval via its original application for metastatic castration-resistant prostate cancer. This marks enzalutamide as a thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Xtandi (enzalutamide)

Snippet

ORIG AP for XTANDI (ENZALUTAMIDE)